$CANB
Can B Corp Stock $canb

$canb Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224033083 Filed on August 19, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$15.27K	$272.3K	$420.6K
YoY Change	-96.36%	-35.26%	-66.91%
Cost Of Revenue	$415.8K	$665.5K	$934.4K
YoY Change	-66.35%	-28.78%	-9.35%
Gross Profit	-$400.5K	-$393.2K	-$513.8K
YoY Change	-50.95%	-23.48%	-313.93%
Gross Profit Margin	-2623.27%	-144.4%	-122.17%
Selling, General & Admin	$2.432M	$1.174M	$1.308M
YoY Change	-11.92%	-10.24%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$29.17K	$348.8K
YoY Change		-91.64%	-4.83%
% of Gross Profit
Operating Expenses	$2.432M	$1.174M	$1.308M
YoY Change	-11.92%	-10.24%	-27.3%
Operating Profit	-$2.833M	-$1.567M	-$1.822M
YoY Change	-20.83%	-13.98%	16.87%
Interest Expense		-$463.4K	$416.4K
YoY Change		-211.28%	143.27%
% of Operating Profit
Other Income/Expense, Net	-$429.7K	-$461.6K	-$205.4K
YoY Change	-26.83%	124.73%	135.34%
Pretax Income	-$3.263M	-$2.029M	-$2.027M
YoY Change	-21.67%	0.08%	23.16%
Income Tax
% Of Pretax Income
Net Earnings	-$3.263M	-$2.029M	-$2.027M
YoY Change	-21.67%	0.08%	23.16%
Net Earnings / Revenue	-21367.56%	-745.03%	-481.94%
Basic Earnings Per Share	-$0.05	-$0.04	-$0.37
Diluted Earnings Per Share	-$0.05	-$0.04	-$0.37
COMMON SHARES
Basic Shares Outstanding	63.66M shares	49.34M shares	5.397M shares
Diluted Shares Outstanding	65.44M shares	54.63M shares	5.553M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$0.00	$123.5K
YoY Change		-100.0%	-0.49%
Cash & Equivalents	$7.879K		$123.4K
Short-Term Investments
Other Short-Term Assets		$10.06K	$29.14K
YoY Change		-65.48%	554.83%
Inventory	$155.9K	$563.4K	$1.554M
Prepaid Expenses
Receivables	$1.420M	$3.405M	$6.719M
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$1.594M	$3.978M	$8.426M
YoY Change	-79.12%	-52.78%	2.19%
LONG-TERM ASSETS
Property, Plant & Equipment		$619.9K	$4.802M
YoY Change		-87.09%	-25.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$16.56K	$16.63K	$13.14K
YoY Change	26.0%	26.54%	0.0%
Total Long-Term Assets	$262.3K	$941.6K	$6.156M
YoY Change	-95.18%	-84.7%	-29.97%
TOTAL ASSETS
Total Short-Term Assets	$1.594M	$3.978M	$8.426M
Total Long-Term Assets	$262.3K	$941.6K	$6.156M
Total Assets	$1.856M	$4.920M	$14.58M
YoY Change	-85.8%	-66.26%	-14.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.631M	$2.614M	$3.679M
YoY Change	-35.0%	-28.94%	34.73%
Accrued Expenses		$65.77K	$405.5K
YoY Change		-83.78%	157.16%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due		$7.983M	$8.623M
YoY Change		-7.42%	36.55%
Total Short-Term Liabilities	$11.64M	$11.11M	$13.72M
YoY Change	-9.43%	-19.02%	31.29%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00	$305.5K
YoY Change		-100.0%	-67.65%
Total Long-Term Liabilities		$0.00	$305.5K
YoY Change		-100.0%	-67.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.64M	$11.11M	$13.72M
Total Long-Term Liabilities		$0.00	$305.5K
Total Liabilities	$11.64M	$11.11M	$14.03M
YoY Change	-9.43%	-20.78%	23.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$113.9M	-$110.7M	-$96.46M
YoY Change	13.23%	14.74%	16.36%
Common Stock	$84.82M	$85.15M	$80.30M
YoY Change	2.59%	6.04%	3.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$572.7K	$572.7K	$572.7K
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	-$9.788M	-$6.191M	$554.9K
YoY Change
Total Liabilities & Shareholders Equity	$1.856M	$4.920M	$14.58M
YoY Change	-85.8%	-66.26%	-14.4%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$3.263M	-$2.029M	-$2.027M
YoY Change	-21.67%	0.08%	23.16%
Depreciation, Depletion And Amortization		$29.17K	$348.8K
YoY Change		-91.64%	-4.83%
Cash From Operating Activities		-$131.1K	-$343.2K
YoY Change		-61.81%	30.84%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$3.870K	$0.00
YoY Change
Cash From Investing Activities		-$3.870K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		108.2K	270.4K
YoY Change		-59.98%	-0.36%
NET CHANGE
Cash From Operating Activities		-131.1K	-343.2K
Cash From Investing Activities		-3.870K	0.000
Cash From Financing Activities		108.2K	270.4K
Net Change In Cash		-26.73K	-72.81K
YoY Change		-63.29%	-903.64%
FREE CASH FLOW
Cash From Operating Activities		-$131.1K	-$343.2K
Capital Expenditures			$0.00
Free Cash Flow			-$343.2K
YoY Change			30.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
	CANB	Contract Settlement ContractSettlement		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	CANB	Cancellation Of Debt CancellationOfDebt		usd
	CANB	Stockbased Consulting Expense StockbasedConsultingExpense		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	CANB	Issuance Of Common Stock In Lieu Of Repayments Of Notes Payable IssuanceOfCommonStockInLieuOfRepaymentsOfNotesPayable		usd
	CANB	Issuance Of Common Stock For Contract Settlement IssuanceOfCommonStockForContractSettlement		usd
	CANB	Issuance Of Note Payable In Connection With Note Extension IssuanceOfNotePayableInConnectionWithNoteExtension		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	CANB	Debt Discount Associated With Convertible Note DebtDiscountAssociatedWithConvertibleNote		usd
	CANB	Issuance Of Common Stock Warrants And Commitment Shares In Connection With Convertible Promissory Note IssuanceOfCommonStockWarrantsAndCommitmentSharesInConnectionWithConvertiblePromissoryNote		usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure		usd
	CANB	Issuance Of Warrant Liabilities IssuanceOfWarrantLiabilities		usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure		usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure		usd
CY2024Q2	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross		usd
CY2024Q2	CANB	Finite Lived Technology Ip And Patents FiniteLivedTechnologyIpAndPatents		usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross		usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q2	us-gaap	Share Price SharePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths		usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	619907	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65771	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2614157	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1997643	usd
CY2024Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	7982587	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	8811596	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1766	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	65771	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	254391	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11111365	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11422639	usd
CY2024Q2	us-gaap	Liabilities Liabilities	11111365	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11422639	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61872981	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61872981	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32753196	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32753196	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	85152193	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	83020998	usd
CY2024Q2	CANB	Common Stock Issuable No Par Value CommonStockIssuableNoParValue	0
CY2023Q4	CANB	Common Stock Issuable No Par Value CommonStockIssuableNoParValue	0
CY2024Q2	CANB	Common Stock Issuable Shares CommonStockIssuableShares	36248	shares
CY2023Q4	CANB	Common Stock Issuable Shares CommonStockIssuableShares	36248	shares
CY2024Q2	CANB	Common Stock Issuable Value CommonStockIssuableValue	119586	usd
CY2023Q4	CANB	Common Stock Issuable Value CommonStockIssuableValue	119586	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	572678	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	572678	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11559910	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10396274	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110670490	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102480698	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-6191436	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1296475	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4919929	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10126164	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	420593	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	641383	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1359898	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	934425	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1858632	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1459002	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-513832	usd
	us-gaap	Gross Profit GrossProfit	-1217249	usd
	us-gaap	Gross Profit GrossProfit	-99104	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1307780	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2861894	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3157410	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-3142769	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1307780	usd
	us-gaap	Operating Expenses OperatingExpenses	6004663	usd
	us-gaap	Operating Expenses OperatingExpenses	3157410	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1821612	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7221912	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3256514	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-101050	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1766	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-180468	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	416415	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	969548	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	750382	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	109964	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-98	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69974	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-205401	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-967880	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-499940	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2027013	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8189792	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3756454	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9596	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2027013	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8189792	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3766050	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54631753	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54631753	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5553317	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5553317	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45984283	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45984283	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5227618	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5227618	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-5314741	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	487428	usd
CY2024Q2	CANB	Stock Issued During Period Value Contract Settlement StockIssuedDuringPeriodValueContractSettlement	579000	usd
CY2024Q2	CANB	Issuance Of Common Stock In Lieu Of Interest Payment IssuanceOfCommonStockInLieuOfInterestPayment	82500	usd
CY2024Q2	CANB	Stock Issuance Of Common Stock With Note Extension Value StockIssuanceOfCommonStockWithNoteExtensionValue	3000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2028623	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-6191436	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2454236	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	74250	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	46875	usd
CY2023Q2	CANB	Issuance Of Common Stock In Lieu Of Interest Payment IssuanceOfCommonStockInLieuOfInterestPayment	6538	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2027013	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	554887	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1296475	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	487428	usd
	CANB	Stock Issuance Of Common Stock For Note Repayments StockIssuanceOfCommonStockForNoteRepayments	964764	usd
	CANB	Stock Issued During Period Value Contract Settlement StockIssuedDuringPeriodValueContractSettlement	579000	usd
	CANB	Stock Issuance Of Common Stock With Note Extension Value StockIssuanceOfCommonStockWithNoteExtensionValue	3000	usd
	CANB	Issuance Of Common Stock In Lieu Of Interest Payment IssuanceOfCommonStockInLieuOfInterestPayment	97003	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1163636	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8189792	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-6191436	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2697925	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2697925	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	595807	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	46875	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	937787	usd
	CANB	Issuance Of Common Stock In Lieu Of Interest Payment IssuanceOfCommonStockInLieuOfInterestPayment	42543	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3766050	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	554887	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	554887	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8189792	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3766050	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1163636	usd
	us-gaap	Depreciation Depreciation	343607	usd
	us-gaap	Depreciation Depreciation	692691	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	343428	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	378547	usd
	CANB	Contract Settlement ContractSettlement	-579000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	95144	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3142769	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	63433	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	61124	usd
	CANB	Cancellation Of Debt CancellationOfDebt	-110000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1766	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-180468	usd
	CANB	Stockbased Interest Expense StockbasedInterestExpense	97003	usd
	CANB	Stockbased Interest Expense StockbasedInterestExpense	42543	usd
	CANB	Stockbased Consulting Expense StockbasedConsultingExpense	595807	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-255003	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	194061	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1056172	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-470251	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	5925	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	8114	usd
	CANB	Increase Decrease In Lease Right Of Use Asset IncreaseDecreaseInLeaseRightOfUseAsset	-40760	usd
	CANB	Increase Decrease In Lease Right Of Use Asset IncreaseDecreaseInLeaseRightOfUseAsset	-142	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3487	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1106943	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	538492	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	223789	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	85928	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1249307	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits	3867	usd
	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits	70000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3867	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-85000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	150000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2140000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	357674	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	621443	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	178000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	91607	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	44000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-116067	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1384557	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-34006	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	50251	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34006	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	73194	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	123445	usd
	CANB	Issuance Of Common Stock In Lieu Of Repayments Of Notes Payable IssuanceOfCommonStockInLieuOfRepaymentsOfNotesPayable	964764	usd
	CANB	Issuance Of Common Stock For Contract Settlement IssuanceOfCommonStockForContractSettlement	579000	usd
	CANB	Issuance Of Note Payable In Connection With Note Extension IssuanceOfNotePayableInConnectionWithNoteExtension	250000	usd
	us-gaap	Stock Issued1 StockIssued1	46875	usd
	CANB	Issuance Of Common Stock For Payables IssuanceOfCommonStockForPayables	487428	usd
	CANB	Debt Discount Associated With Convertible Note DebtDiscountAssociatedWithConvertibleNote	273529	usd
	CANB	Issuance Of Common Stock Warrants And Commitment Shares In Connection With Convertible Promissory Note IssuanceOfCommonStockWarrantsAndCommitmentSharesInConnectionWithConvertiblePromissoryNote	937787	usd
CY2024Q2	CANB	Working Capital WorkingCapital	7133025	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8189792	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110670490	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zJKQqcqq1cMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zp6JcLmXm9ed">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses in those financial statements. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, inventory, intangible assets and other long-lived assets, income taxes and deferred taxes. Descriptions of these policies are discussed in the Company’s 2023 Form 10-K. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and adjusts when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Notes Payable NotesPayable	242107	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z1mQdUArGpje" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zlHd98QThFR3">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the prior year consolidated financial statements have been reclassified to conform to the current year presentation. These reclassification adjustments had no effect on the Company’s previously reported net loss. December 2023 revenues and accounts payable were misstated and a correction of $<span id="xdx_907_ecustom--RevenueTransactionCost_c20231231__20231231_zvXJqchOK4me" title="Revenue transaction cost">52,400</span> was made related to a transaction reversal with a vendor.</span></p>
CY2023Q4	CANB	Revenue Transaction Cost RevenueTransactionCost	52400	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1766	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	203043	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-180468	usd
CY2023Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	123625	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1766	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1766	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1766	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	191025	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1196112	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	372345	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	423430	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	563370	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1619542	usd
CY2024Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2706	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	21724	usd
CY2023Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	12378	usd
CY2024Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	468264	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	6828083	usd
CY2024Q2	CANB	Medical Equipment MedicalEquipment	776396	usd
CY2023Q4	CANB	Medical Equipment MedicalEquipment	776396	usd
CY2024Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	26902	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	26902	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1274268	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7665483	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	654361	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3559200	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	619907	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4106283	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	343607	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	692691	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3142769	usd
CY2023Q4	CANB	Finite Lived Technology Ip And Patents FiniteLivedTechnologyIpAndPatents	119998	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	119998	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24854	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	95144	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	95144	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1354210	usd
CY2023Q4	CANB	Percentage Of Outstanding Common Stock PercentageOfOutstandingCommonStock	0.0999	pure
CY2022	CANB	Purchase Amount Of Future Receivables PurchaseAmountOfFutureReceivables	450000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80000	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	198248	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.24	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12223331	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.08
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M20D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	27019284	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.04
	CANB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	39242615	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.99
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y5M1D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1163636	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	66750	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	66750	usd

Files In Submission

Name	View Source	Status
0001493152-24-033083-index-headers.html	Edgar Link	pending
0001493152-24-033083-index.html	Edgar Link	pending
0001493152-24-033083.txt	Edgar Link	pending
0001493152-24-033083-xbrl.zip	Edgar Link	pending
canb-20240630.xsd	Edgar Link	pending
ex10-73.htm	Edgar Link	pending
ex10-73_001.jpg	Edgar Link	pending
ex10-73_002.jpg	Edgar Link	pending
ex10-73_003.jpg	Edgar Link	pending
ex10-73_004.jpg	Edgar Link	pending
ex10-73_005.jpg	Edgar Link	pending
ex10-73_006.jpg	Edgar Link	pending
ex10-73_007.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
canb-20240630_cal.xml	Edgar Link	unprocessable
canb-20240630_lab.xml	Edgar Link	unprocessable
canb-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
canb-20240630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CANB
Can B Corp Stock $canb

2024 Q3 Form 10-Q Financial Statement

#000149315224033083 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CANB Can B Corp Stock $canb

2024 Q3 Form 10-Q Financial Statement

#000149315224033083 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CANB
Can B Corp Stock $canb